Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 6/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.50 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.49 |
| ▸ | CDK1 | P06493 | 1/20 | 0.49 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.49 |
| ▸ | GSK3A | P49840 | 1/20 | 0.49 |
| ▸ | GSK3B | P49841 | 1/20 | 0.49 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.49 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Acetate SCHEMBL28283549 | 0.84 | KDM4E (0.48) | IDO1NPY5RGAA | |
| SCHEMBL27908051 | 0.80 | IDO1 (0.54) | IDO1CYP3A4CYP11B1CYP11B2LTA4H | |
| SCHEMBL872211 | 0.79 | LTA4H (0.64) | IDO1CYP3A4CYP11B1CYP11B2LTA4H | |
| SCHEMBL871586 | 0.77 | IDO1 (0.64) | IDO1CYP3A4CYP11B1CYP11B2NPY5R | |
| SCHEMBL21128574 | 0.75 | IDO1 (0.74) | IDO1CYP3A4CYP11B1CYP11B2LTA4H | |
| SCHEMBL28238890 | 0.75 | CYP17A1 (0.52) | IDO1CYP3A4CYP11B1CYP11B2NPY5R | |
| SCHEMBL29578589 | 0.75 | CYP17A1 (0.52) | IDO1CYP3A4CYP11B1CYP11B2NPY5R | |
| SCHEMBL25262025 | 0.74 | IDO1 (0.64) | IDO1CYP3A4CYP11B1CYP11B2CYP2D6 | |
| SCHEMBL7443518 | 0.74 | GAA (0.56) | CYP3A4NPY5RGAACYP2D6CYP2C9 | |
| SCHEMBL872416 | 0.74 | IDO1 (1.00) | IDO1CYP3A4CYP11B1CYP11B2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4525821-A1 | COMPOSITIONS THAT ENHANCE THE COOLING EFFECT | Firmenich Incorporated (US) | 2025-03-26 | — | — | EP | claimed |
| WO-2024011086-A1 | COMPOSITIONS THAT ENHANCE THE COOLING EFFECT | FIRMENICH INCORPORATED (US) | 2024-01-11 | — | — | WO | claimed |
| CN-109438520-B | Cyclometallated tetradentate Pt (II) complexes | 通用显示公司 | 2021-09-07 | — | — | CN | disclosed |
| EP-3032625-B1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC (JP) | 2020-01-08 | — | — | EP | disclosed |
| EP-3264506-A1 | METHOD FOR PRODUCING A FUEL CELL SEPARATOR | Nisshinbo Chemical Inc. (JP) | 2018-01-03 | — | — | EP | disclosed |
| EP-2458667-B1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC (JP) | 2017-05-24 | — | — | EP | disclosed |
| EP-2763223-B1 | POROUS SEPARATOR FOR FUEL CELLS | NISSHINBO CHEMICAL INC (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-9493698-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-15 | — | — | US | disclosed |
| US-9493698-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-15 | — | — | US | disclosed |
| US-9493698-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-15 | — | — | US | disclosed |
| EP-3032625-A1 | FUEL CELL SEPARATOR | Nisshinbo Chemical Inc. (JP) | 2016-06-15 | — | — | EP | disclosed |
| EP-1317445-B1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS | ANORMED INC (CA) | 2009-03-11 | — | — | EP | disclosed |
| US-7396840-B2 | Chemokine receptor binding heterocyclic compounds | GENZYME CORPORATION (US) | 2008-07-08 | — | — | US | disclosed |
| US-7084155-B2 | Chemokine receptor binding heterocyclic compounds | ANORMED (CA) | 2006-08-01 | — | — | US | disclosed |
| US-20060128750-A1 | Chemokine receptor binding heterocyclic compounds | GENZYME CORPORATION | 2006-06-15 | — | — | US | disclosed |
| US-6864265-B2 | Chemokine receptor binding heterocyclic compounds | ANORMED, INC. (CA) | 2005-03-08 | — | — | US | disclosed |
| US-20040220207-A1 | Chemokine receptor binding heterocyclic compounds | GENZYME CORPORATION | 2004-11-04 | — | — | US | disclosed |
| EP-1317445-A2 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS | ANORMED INC. (CA) | 2003-06-11 | — | — | EP | disclosed |
| US-20030018046-A1 | Chemokine receptor binding heterocyclic compounds | GENZYME CORPORATION | 2003-01-23 | — | — | US | disclosed |
| WO-2002022600-A2 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS | ANORMED INC. (CA) | 2002-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040220207-A1 | Chemokine receptor binding heterocyclic compounds | CXCR3, ACKR3, CCR2 | IDO1 2001/4885CYP3A4 3162/4885CYP11B1 711/4885 |
| US-20060128750-A1 | Chemokine receptor binding heterocyclic compounds | CXCR4, CCR5, CXCR3 | IDO1 1578/4885CYP3A4 2593/4885CYP11B1 1034/4885 |
| US-20030018046-A1 | Chemokine receptor binding heterocyclic compounds | CXCR3, ACKR3, CCR2 | IDO1 2001/4885CYP3A4 3162/4885CYP11B1 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.